HPV screening for cervical cancer in rural India. Mwanahamuntu MH, Sahasrabuddhe VV, Parham GP (2009) N Engl J Med 361: 305; author reply 306 Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality. Sahasrabuddhe VV, Sherman ME (2012) J Natl Cancer Inst 104: 1698-701 Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. Wilson LE, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N (2013) Int J Cancer 133: 2172-81 Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India. Sahasrabuddhe VV, Bhosale RA, Kavatkar AN, Nagwanshi CA, Joshi SN, Jenkins CA, Shepherd BE, Kelkar RS, Sahay S, Risbud AR, Vermund SH, Mehendale SM (2012) Int J Cancer 130: 234-40 Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection. Wilson L, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N (2014) J Infect Dis 210: 448-55 Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. Klein RS, Ho GY, Vermund SH, Fleming I, Burk RD (1994) J Infect Dis 170: 1404-9 Impact of the Bethesda System. Jones HW (1995) Cancer 76: 1914-8 Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates. Lang Kuhs KA, Porras C, Schiller JT, Rodriguez AC, Schiffman M, Gonzalez P, Wacholder S, Ghosh A, Li Y, Lowy DR, Kreimer AR, Poncelet S, Schussler J, Quint W, van Doorn LJ, Sherman ME, Sidawy M, Herrero R, Hildesheim A, Safaeian M, Costa Rica Vaccine Trial Group (2014) Am J Epidemiol 180: 599-607 Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. Bateman AC, Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Kapambwe S, Katundu K, Nkole T, Mulundika J, Pfaendler KS, Hicks ML, Shibemba A, Vermund SH, Stringer JS, Chibwesha CJ (2014) J Acquir Immune Defic Syndr 67: 212-5 Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM (2000) Arch Pediatr Adolesc Med 154: 127-34 Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, Parham GP (2008) Gynecol Oncol 110: 402-7 Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH (2006) Gynecol Oncol 103: 1017-22 Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. Sahasrabuddhe VV, Bhosale RA, Joshi SN, Kavatkar AN, Nagwanshi CA, Kelkar RS, Jenkins CA, Shepherd BE, Sahay S, Risbud AR, Vermund SH, Mehendale SM (2010) PLoS One 5: e8634 HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India. Mane A, Nirmalkar A, Risbud AR, Vermund SH, Mehendale SM, Sahasrabuddhe VV (2012) PLoS One 7: e38731 Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. Parham GP, Mwanahamuntu MH, Kapambwe S, Muwonge R, Bateman AC, Blevins M, Chibwesha CJ, Pfaendler KS, Mudenda V, Shibemba AL, Chisele S, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Chi BH, Stringer JS, Sankaranarayanan R, Sahasrabuddhe VV (2015) PLoS One 10: e0122169 The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study. Bateman AC, Katundu K, Mwanahamuntu MH, Kapambwe S, Sahasrabuddhe VV, Hicks ML, Chi BH, Stringer JS, Parham GP, Chibwesha CJ (2015) BMC Cancer 15: 541 Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. Sahasrabuddhe VV, Gravitt PE, Dunn ST, Robbins D, Brown D, Allen RA, Eby YJ, Smith KM, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N (2014) J Clin Virol 60: 414-7 Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: Challenges in detecting dysplasia. Adkins BD, Barlow AB, Jack A, Schultenover SJ, Desouki MM, Coogan AC, Weiss VL (2018) Cytopathology 29: 281-287 HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study. Zhang HY, Tiggelaar SM, Sahasrabuddhe VV, Smith JS, Jiang CQ, Mei RB, Wang XG, Li ZA, Qiao YL (2012) Asian Pac J Cancer Prev 13: 91-6 Mandatory fortification with folic acid in the United States is not associated with changes in the degree or the pattern of global DNA methylation in cells involved in cervical carcinogenesis. Piyathilake CJ, Azrad M, Jhala D, Macaluso M, Kabagambe EK, Brill I, Niveleau A, Jhala N, Grizzle WE (2006) Cancer Biomark 2: 259-66 Treatment of cervical dysplasia with large loop excision of the transformation zone: is endocervical curettage necessary? Naumann RW, Crispens MA, Alvarez RD, Partridge EE, Shingleton HM, Kilgore LC (1996) South Med J 89: 961-5 Inadequate follow-up for abnormal Pap smears in an urban population. Peterson NB, Han J, Freund KM (2003) J Natl Med Assoc 95: 825-32 Split-sample analysis of discarded cells from liquid-based Pap smear sampling devices. Rinas AC, Mittman BW, Le LV, Hartmann K, Cayless J, Singh HK (2006) Acta Cytol 50: 55-62
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.